3 completed. 2 Phase 3, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Nexstar Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Inhalation of Liposomal Amphotericin B to Prevent Invasive Aspergillosis nebulised liposomal amphotericin B - Aspergillosis | Phase 2 / Phase 3 | Completed | Erasmus Medical Center | 320 | 2000-01-01 | 2006-08-18 |
| Lurtotecan Liposome in Treating Patients With Advanced Solid Tumors lurtotecan liposome - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Completed | NCIC Clinical Trials Group | 37 | 1999-02-25 | 2020-04-09 |
| A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma. Daunorubicin (liposomal), Bleomycin sulfate, Vincristine sulfate - Sarcoma, Kaposi, HIV Infections | Phase 3 | Completed | Nexstar Pharmaceuticals | 2005-06-24 |
Acquired Immunodeficiency Syndrome (1) · Aspergillosis (1) · HIV Infections (1) · Hematologic Diseases (1) · Mycoses (1) · Neutropenia (1) · Sarcoma, Kaposi (1)
Bleomycin (1) · Daunorubicin (1) · Doxorubicin (1) · Vincristine (1)
Canada (1) · Netherlands (1) · United States (1)
A Vulto, PhD (1) · Bart JA Rijnders, MD, PhD (1) · Jan J Cornelissen, MD, PhD (1) · Karen A. Gelmon, MD (1) · Lennert Slobbe, MD (1) · M J Becker, PhD (1) · Siem de Marie, MD, PhD (1)